Panacea Life Sciences Holdings, Inc. Stock: price and insider trades · United States
No insider purchase over the last 90 days. The latest, by Buttorff Leslie, was filed 20 Sept 2023.
Panacea Life Sciences Holdings, Inc.: what insiders have been doing
Every trade that managers of Panacea Life Sciences Holdings, Inc. disclose to SEC (Form 4) is tracked on this page. The company sits in the Health Care sector. The past year has been quiet: not a single insider filing for Panacea Life Sciences Holdings, Inc. The previous disclosure was published on 20 September 2023.
Looking back to 2019, when coverage begins, insiders filed 43 purchases and no sales.
Elsewhere in the same sector, our signals recently picked up insider purchases at Dynavox Group AB and EssilorLuxottica. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Since the insiders bought
- -35.6%Entry US$0.20 · Close at T+365 US$0.13
- +160.8%Entry US$0.09 · Close at T+365 US$0.25
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Financial data
as of FY 2023FY ended December 2023 · cache
- 20,000 shares@ US$0.23651.2% of flowCommon StockSEC:0001493152-23-033155:0Canonical exit: 17 Dec 2023 (T+90)
- 3,000 shares@ US$0.43250.3% of flowCommon StockSEC:0001493152-23-020928:1Canonical exit: 7 Sept 2023 (T+90)
- 760,000 shares@ US$0.5094.3% of flowCommon StockSEC:0001493152-23-020928:0
- 1,500 shares@ US$0.520.2% of flowCommon StockSEC:0001493152-23-018753:1Canonical exit: 17 Aug 2023 (T+90)
- 500 shares@ US$0.4980.1% of flowCommon StockSEC:0001493152-23-018753:2Canonical exit: 21 Aug 2023 (T+90)
- 4,500 shares@ US$0.510.6% of flowCommon StockSEC:0001493152-23-018753:0Canonical exit: 17 Aug 2023 (T+90)
- 1,500 shares@ US$0.430.2% of flowCommon StockSEC:0001493152-23-016009:1Canonical exit: 6 Aug 2023 (T+90)
- 2,300 shares@ US$0.3770.2% of flowCommon StockSEC:0001493152-23-016009:2Canonical exit: 7 Aug 2023 (T+90)
- 11,500 shares@ US$0.491.4% of flowCommon StockSEC:0001493152-23-016009:0Canonical exit: 3 Aug 2023 (T+90)
- 1,000 shares@ US$0.320.1% of flowCommon StockSEC:0001493152-23-013730:0Canonical exit: 24 Jul 2023 (T+90)
- 3,500 shares@ US$0.38030.3% of flowCommon StockSEC:0001493152-23-013730:1Canonical exit: 24 Jul 2023 (T+90)
- 5,500 shares@ US$0.39760.5% of flowCommon StockSEC:0001493152-23-013730:2Canonical exit: 25 Jul 2023 (T+90)
- 3,200 shares@ US$0.350.3% of flowCommon StockSEC:0001493152-23-011314:1Canonical exit: 3 Jul 2023 (T+90)
- 2,500 shares@ US$0.330.2% of flowCommon StockSEC:0001493152-23-011314:2Canonical exit: 4 Jul 2023 (T+90)
- 1,000 shares@ US$0.360.1% of flowCommon StockSEC:0001493152-23-011314:0Canonical exit: 2 Jul 2023 (T+90)
- 1,000 shares@ US$0.190.0% of flowCommon StockSEC:0001493152-23-006398:2Canonical exit: 28 May 2023 (T+90)
- 2,000 shares@ US$0.17250.1% of flowCommon StockSEC:0001493152-23-006398:1Canonical exit: 28 May 2023 (T+90)
- 1,000 shares@ US$0.190.0% of flowCommon StockSEC:0001493152-23-006398:0Canonical exit: 27 May 2023 (T+90)
- 2,500 shares@ US$0.12550.1% of flowCommon StockSEC:0001493152-22-024273:1Canonical exit: 24 Nov 2022 (T+90)
- 1,000 shares@ US$0.150.0% of flowCommon StockSEC:0001493152-22-024273:2Canonical exit: 24 Nov 2022 (T+90)
- 11,500 shares@ US$0.13780.4% of flowCommon StockSEC:0001493152-22-024273:0Canonical exit: 24 Nov 2022 (T+90)
- 5,000 shares@ US$0.12832.7% of flowCommon StockSEC:0001493152-22-022609:1Canonical exit: 9 Nov 2022 (T+90)
- 5,000 shares@ US$0.13534.4% of flowCommon StockSEC:0001493152-22-022609:2Canonical exit: 9 Nov 2022 (T+90)
- 5,000 shares@ US$0.129100.0% of flowCommon StockSEC:0001493152-22-022609:0Canonical exit: 9 Nov 2022 (T+90)
- 5,100 shares@ US$0.100.1% of flowCommon StockSEC:0001493152-22-021447:1Canonical exit: 2 Nov 2022 (T+90)
25 of 65 declarations
About Panacea Life Sciences Holdings, Inc.
Panacea Life Sciences Holdings, Inc. is a company focused on the health and pharmaceutical sector. It specializes in the development of cannabinoid-based products and innovative health solutions.
Recent ranked signals in the same sector
Purchases our model currently ranks for the recommendations list.
All recommendations
